ST6GAL1 is known to promote growth, survival, and metastasis, and it is upregulated in various types of cancer (including pancreatic, prostate, breast, and ovarian cancer) (73–76), while being downregulated in hepatocellular carcinoma (77). Here, ST6GAL1 is linked to hepatocellular carcinoma.